JP2004525111A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004525111A5 JP2004525111A5 JP2002565606A JP2002565606A JP2004525111A5 JP 2004525111 A5 JP2004525111 A5 JP 2004525111A5 JP 2002565606 A JP2002565606 A JP 2002565606A JP 2002565606 A JP2002565606 A JP 2002565606A JP 2004525111 A5 JP2004525111 A5 JP 2004525111A5
- Authority
- JP
- Japan
- Prior art keywords
- depsipeptide
- animal
- formula
- crystalline form
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10104362A DE10104362A1 (de) | 2001-02-01 | 2001-02-01 | Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit |
| PCT/EP2002/000541 WO2002066048A1 (de) | 2001-02-01 | 2002-01-21 | Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004525111A JP2004525111A (ja) | 2004-08-19 |
| JP2004525111A5 true JP2004525111A5 (enExample) | 2005-12-22 |
Family
ID=7672376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002565606A Pending JP2004525111A (ja) | 2001-02-01 | 2002-01-21 | 改良された強度を有する環式デプシペプチドの結晶変態 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20040115483A1 (enExample) |
| EP (1) | EP1357932B1 (enExample) |
| JP (1) | JP2004525111A (enExample) |
| KR (2) | KR20030081378A (enExample) |
| CN (1) | CN1278735C (enExample) |
| AT (1) | ATE284703T1 (enExample) |
| AU (1) | AU2002226415B2 (enExample) |
| BR (1) | BRPI0206841B8 (enExample) |
| CA (1) | CA2436832C (enExample) |
| CR (1) | CR7039A (enExample) |
| CZ (1) | CZ299564B6 (enExample) |
| DE (2) | DE10104362A1 (enExample) |
| EE (1) | EE05490B1 (enExample) |
| ES (1) | ES2233805T3 (enExample) |
| HR (1) | HRP20030635A2 (enExample) |
| HU (1) | HU229229B1 (enExample) |
| IL (2) | IL157026A0 (enExample) |
| MX (1) | MXPA03006866A (enExample) |
| NO (1) | NO331289B1 (enExample) |
| NZ (1) | NZ527230A (enExample) |
| PL (1) | PL213106B1 (enExample) |
| PT (1) | PT1357932E (enExample) |
| RU (1) | RU2300390C2 (enExample) |
| SK (1) | SK286280B6 (enExample) |
| UA (1) | UA74623C2 (enExample) |
| WO (1) | WO2002066048A1 (enExample) |
| ZA (1) | ZA200305864B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080003546A1 (en) * | 2006-06-29 | 2008-01-03 | Dunbar Kimberly L | Animated digital charted yarncraft instruction |
| HUE055535T2 (hu) | 2015-05-20 | 2021-12-28 | Boehringer Ingelheim Animal Health Usa Inc | Féreghajtó depszipeptid-vegyületek |
| CN108699052B (zh) | 2015-12-28 | 2022-04-29 | 勃林格殷格翰动物保健美国公司 | 驱虫缩酚酸肽化合物 |
| JP2020504710A (ja) | 2016-11-16 | 2020-02-13 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 駆虫性デプシペプチド化合物 |
| CN114195732A (zh) * | 2022-01-04 | 2022-03-18 | 丽珠集团福州福兴医药有限公司 | 一种艾默德斯的单晶型iii及其制备方法 |
| CN114262303A (zh) * | 2022-01-04 | 2022-04-01 | 丽珠集团福州福兴医药有限公司 | 一种艾默德斯的单晶型ii及其制备方法 |
| CN115010680A (zh) * | 2022-07-13 | 2022-09-06 | 丽珠集团福州福兴医药有限公司 | 单晶型i的艾默德斯及其制备方法 |
| CN114989110A (zh) * | 2022-07-13 | 2022-09-02 | 丽珠集团福州福兴医药有限公司 | 单晶型ⅳ的艾默德斯及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2096907A (en) * | 1981-04-22 | 1982-10-27 | Exxon Research Engineering Co | Distillation column with steam stripping |
| NZ249588A (en) * | 1992-03-17 | 1996-08-27 | Fujisawa Pharmaceutical Co | Anthelmintic agent |
| DE4317458A1 (de) * | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
| DE4400464A1 (de) * | 1994-01-11 | 1995-07-13 | Bayer Ag | Endoparasitizide Mittel |
| JP3985050B2 (ja) * | 1995-06-30 | 2007-10-03 | アステラス製薬株式会社 | デプシペプチド誘導体その製造法およびその新規中間体 |
| NZ318515A (en) * | 1995-09-22 | 2000-05-26 | Bayer Ag | Cyclodepsipeptide PF1022 derivatives and compositions thereof |
| WO1999024412A1 (en) * | 1997-11-10 | 1999-05-20 | Fujisawa Pharmaceutical Co., Ltd. | Novel crystal of depsipeptide derivative and process for producing the same |
| DE10008128A1 (de) * | 2000-02-22 | 2001-08-23 | Bayer Ag | Endoparasitizide Mittel |
| DE10031044A1 (de) * | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere |
-
2001
- 2001-02-01 DE DE10104362A patent/DE10104362A1/de not_active Withdrawn
-
2002
- 2002-01-21 PT PT02716073T patent/PT1357932E/pt unknown
- 2002-01-21 BR BR0206841-9 patent/BRPI0206841B8/pt not_active IP Right Cessation
- 2002-01-21 ES ES02716073T patent/ES2233805T3/es not_active Expired - Lifetime
- 2002-01-21 KR KR10-2003-7009110A patent/KR20030081378A/ko not_active Ceased
- 2002-01-21 IL IL15702602A patent/IL157026A0/xx unknown
- 2002-01-21 KR KR1020097006790A patent/KR20090041451A/ko not_active Ceased
- 2002-01-21 EP EP02716073A patent/EP1357932B1/de not_active Expired - Lifetime
- 2002-01-21 JP JP2002565606A patent/JP2004525111A/ja active Pending
- 2002-01-21 DE DE50201777T patent/DE50201777D1/de not_active Expired - Lifetime
- 2002-01-21 UA UA2003088108A patent/UA74623C2/uk unknown
- 2002-01-21 HR HR20030635A patent/HRP20030635A2/hr not_active Application Discontinuation
- 2002-01-21 EE EEP200300365A patent/EE05490B1/xx unknown
- 2002-01-21 PL PL362389A patent/PL213106B1/pl unknown
- 2002-01-21 AT AT02716073T patent/ATE284703T1/de active
- 2002-01-21 HU HU0302880A patent/HU229229B1/hu unknown
- 2002-01-21 MX MXPA03006866A patent/MXPA03006866A/es active IP Right Grant
- 2002-01-21 NZ NZ527230A patent/NZ527230A/xx not_active IP Right Cessation
- 2002-01-21 CA CA2436832A patent/CA2436832C/en not_active Expired - Lifetime
- 2002-01-21 SK SK988-2003A patent/SK286280B6/sk not_active IP Right Cessation
- 2002-01-21 CZ CZ20032063A patent/CZ299564B6/cs not_active IP Right Cessation
- 2002-01-21 RU RU2003126589/15A patent/RU2300390C2/ru active
- 2002-01-21 AU AU2002226415A patent/AU2002226415B2/en not_active Expired
- 2002-01-21 US US10/470,853 patent/US20040115483A1/en not_active Abandoned
- 2002-01-21 WO PCT/EP2002/000541 patent/WO2002066048A1/de not_active Ceased
- 2002-01-21 CN CNB028044843A patent/CN1278735C/zh not_active Expired - Lifetime
-
2003
- 2003-07-21 IL IL157026A patent/IL157026A/en unknown
- 2003-07-30 CR CR7039A patent/CR7039A/es unknown
- 2003-07-30 ZA ZA200305864A patent/ZA200305864B/en unknown
- 2003-07-30 NO NO20033413A patent/NO331289B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1862458A3 (en) | Therapeutic agents useful for treating pain | |
| JP2005518413A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| CY1115719T1 (el) | Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων | |
| JP2004533444A5 (enExample) | ||
| EP1961748A3 (en) | 2-Hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors | |
| JP2007522220A5 (enExample) | ||
| JP2009504763A5 (enExample) | ||
| JP2009017881A5 (enExample) | ||
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| EP1797878A3 (en) | Benzothiazole derivatives | |
| JP2005053931A5 (enExample) | ||
| CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
| EP1576986A3 (en) | Sustained-release tramadol formulations with 24-hour clinical efficacy | |
| AR045317A1 (es) | Forma cristalina de agonista dl receptor adrenergico b2 | |
| EP2308828A3 (en) | CaSR antagonist | |
| JP2004517098A5 (enExample) | ||
| JP2004525111A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| JP2004532828A5 (enExample) | ||
| JP2004502684A5 (enExample) | ||
| RU2007118691A (ru) | Применение 4-трифторметилфениламида (z)-2-циано-3-гидрокси-бут-2-еновой кислоты для лечения воспалительных заболеваний кишечника | |
| JP2010539091A5 (enExample) | ||
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| JP2008546809A5 (enExample) |